EPIZYME INC - COM (EPZM) Institutional Ownership

CUSIP: 29428V104

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2022

Type / Class
Equity / COM
Symbol
EPZM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 29428V104?
CUSIP 29428V104 identifies EPZM - EPIZYME INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of EPIZYME INC - COM (EPZM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q4 0 $0 -$4,000 0
2022 Q3 218,384 $4,000 -$186,861,294 $0.02 1
2022 Q2 127,185,873 $186,959,424 -$19,845,585 $1.47 86
2022 Q1 112,797,515 $129,726,194 +$35,356,395 $1.15 113
2021 Q4 84,779,726 $212,062,772 -$18,895,269 $2.50 127
2021 Q3 93,676,680 $479,803,021 -$19,984,727 $5.12 113
2021 Q2 95,093,300 $790,193,183 -$4,176,287 $8.31 125
2021 Q1 95,499,733 $831,798,028 -$7,992,634 $8.71 132
2020 Q4 98,990,884 $1,075,076,271 -$6,741,917 $10.86 135
2020 Q3 92,482,999 $1,103,347,621 -$37,302,709 $11.93 149
2020 Q2 93,611,465 $1,503,407,182 +$17,627,121 $16.06 157
2020 Q1 92,587,438 $1,434,786,931 +$1,885,890 $15.51 138
2019 Q4 91,671,282 $2,254,566,079 +$217,606,177 $24.60 129
2019 Q3 80,322,119 $828,478,298 +$904,470 $10.32 107
2019 Q2 79,751,952 $1,000,590,266 +$27,096,141 $12.55 127
2019 Q1 77,877,065 $964,818,171 +$158,642,546 $12.39 118
2018 Q4 66,167,639 $407,489,432 +$27,509,544 $6.16 102
2018 Q3 59,225,232 $627,861,034 -$10,751,160 $10.60 102
2018 Q2 59,953,813 $812,338,254 -$9,764,590 $13.55 105
2018 Q1 59,961,145 $1,064,294,942 +$11,851,257 $17.75 106
2017 Q4 59,637,657 $748,517,414 -$17,861,931 $12.55 99
2017 Q3 60,366,538 $1,149,829,008 +$202,581,167 $19.05 104
2017 Q2 50,134,198 $757,040,570 +$30,323,261 $15.10 107
2017 Q1 47,990,313 $823,022,296 +$52,529,928 $17.15 95
2016 Q4 48,698,461 $589,257,005 +$24,741,791 $12.10 92
2016 Q3 46,723,281 $459,519,996 -$6,166,037 $9.84 96
2016 Q2 47,308,257 $484,441,962 +$11,518,974 $10.24 96
2016 Q1 46,126,532 $558,995,000 +$146,810,642 $12.12 90
2015 Q4 33,915,214 $543,336,589 -$41,000,036 $16.02 88
2015 Q3 36,165,256 $465,071,938 +$10,555,783 $12.86 96
2015 Q2 34,359,974 $824,579,536 +$79,050,851 $24.00 94
2015 Q1 29,419,950 $552,530,869 +$151,147,352 $18.78 100
2014 Q4 23,721,769 $447,608,323 -$17,196,418 $18.87 82
2014 Q3 23,564,833 $638,840,183 +$29,164,119 $27.11 94
2014 Q2 22,451,487 $698,701,484 +$31,508,744 $31.12 82
2014 Q1 21,688,805 $493,848,845 +$137,623,005 $22.77 73